The Major Pathologic Response Project is a collection of clinical trial data and research that can be used to validate surrogate endpoints and identify predictive biomarkers, which may enable better targeting of tumor characteristics.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy policy
You are now leaving lungambitionalliance.com
You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.
Lung Ambition Alliance provides this link as a service to website visitors. Lung Ambition Alliance is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.
Click ‘cancel’ to return to Lung Ambition Alliance’s site or ‘continue’ to proceed.
